Skip to main content
Home Home

User account menu

  • Log in

Main navigation

  • Home
  • Topics
    • Antimicrobials
    • Asthma
    • Biological medicines
    • COVID-19 medicines
    • Cardiovascular disease
    • Equity
    • Focus medicines
    • Gout
    • Hepatitis C
    • Menopause
    • Type 2 diabetes
    • Youth mental health
  • Resources
    • All education/search
    • Brand changes
    • Clinical articles
    • HAH Bulletins
    • Podcasts
    • Recorded webinars
    • Reflect & audit activities
    • Resource hubs
    • Videos
  • EPiC dashboard
    • Go to EPiC
    • Join EPiC
    • EPiC FAQ
    • EPiC Demo
    • About EPiC
  • News
    • Events
    • That's Interesting
    • From The Team

Education

  1. Home
  2. Search

The hub for all your learning resources.

Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.

Viewing their serum urate results may help people to accept gout as a long-term condition requiring ULT

Improving gout outcomes and achieving equity

13 minutes to Read

Gout services vary between regions and populations but one common factor is that success requires a whole-of-team approach. This article introduces the online Gout Guide, a helpful local resource that draws on a range of experience and proven tools to help improve gout outcomes.

Contributor
He Ako Hiringa, reviewed by Dr Sue Ward
27 March 2024
  • Gout
  • Clinical article

Update on gout management

This video is a recording of the live webinar hosted by Mobile Health on 14 March 2024. In this webinar, Professor Nicola Dalbeth gave a clinical update, and provided information about new resources that can be used to support effective gout management.

Contributor
Professor Nicola Dalbeth
22 March 2024
  • Gout
  • Recorded webinars
Microlearning

Ensure adequate allopurinol – titrate to serum urate

The most commonly used maintenance dose of allopurinol is 300mg daily, but this dose may not reduce serum urate enough to suppress gout flares. Find out more about appropriate allopurinol dosing in this microlearning. 

Contributor
He Ako Hiringa
1 March 2024
  • HAH Bulletins
  • Gout
Microlearning

Making hepatitis C history

Chronic hepatitis C can cause cirrhosis, liver failure, cancer and early death. Raising awareness that hep C can be cured with a short course of oral antivirals is vital. Read this microlearning to find out more.

Contributor
He Ako Hiringa
1 February 2024
  • HAH Bulletins
  • Hep C

The latest on the asthma scene: Kids, teens and keeping it green

1 minute to Read + 60 minutes to Watch

This video is a recording of the live webinar hosted by Mobile Health on 30 November 2023. Dr David McNamara explores the importance of childhood asthma diagnosis, management, disparities and inhaler technique. Dr Burrell then discusses the impact of inhaler propellants on the environment, and how we can minimise harm.

14 December 2023
  • Asthma
  • Recorded webinars

Antimicrobial stewardship in Aotearoa: Striving for safe, effective and equitable antimicrobial use

60 minutes to Watch

This video is a recording of the live webinar hosted by Mobile Health on 21 November 2023. Dr Sharon Gardiner explores safe, effective and equitable antimicrobial use and gives an update on development of national guidelines.

Contributor
Dr Sharon Gardiner
6 December 2023
  • Antimicrobials
  • Recorded webinars
Eradicating hepatitis C in Aotearoa

Episode Seven: Eradicating hepatitis C in Aotearoa

1 minute to Read + 30 minutes to Listen

Episode seven of our Legendary Conversations podcast explores hepatitis C. Dr Sarah Hartnall, and nurses Nancy Carey and Bridget Faire discuss hepatitis C testing, treatment, and support networks in Aotearoa. 

Contributor
He Ako Hiringa
5 December 2023
  • Podcast
  • Hep C
Microlearning

Inhaler carbon footprint

Metered dose inhalers such as salbutamol contain hydrofluorocarbon propellants, powerful greenhouse gases that contribute to global warming. Read this microlearning to find out more about inhaler carbon footprint and environmentally friendly alternatives. 

Contributor
He Ako Hiringa
1 December 2023
  • HAH Bulletins
  • Asthma
Hepatitis C targeted for global eradication

Hepatitis C targeted for global eradication

8 minutes to Read

A short course of oral antivirals can cure hepatitis C, but first we have to identify people with chronic infection. Read our article to find out who and how to test for hep C, the supports in place for patients and health providers, and the plan to eradicate hepatitis globally.

Contributor
He Ako Hiringa, reviewed by Professor Ed Gane
28 November 2023
  • Clinical article
  • Hep C
Brand change

Morphine oral liquid

2 minutes to Read

All RA-Morph oral liquid strengths are now out of stock or expired. Wockhardt 10mg/5ml (2mg/ml) and Oramorph 2mg/ml are available instead but supply gaps may occur during April. Oramorph now has Medsafe approval, but Workhardt brand remains a Section 29 medicine.

Read this article for important points to note. 

Contributor
He Ako Hiringa
21 November 2023
  • Brand change
AMR article

Antimicrobial stewardship: World AMR Awareness Week

15 minutes to Read

World AMR Awareness Week occurs 18-24 November every year and aims to improve understanding of antimicrobial resistance (AMR). Our short article looks at this year's theme and provides information and resources that can be used all year round.

Contributor
NAMSIPEG
15 November 2023
  • Antimicrobials
Microlearning

World AMR Awareness Week 18–24 Nov

Antimicrobial resistance (AMR) is a global crisis and a growing problem in Aotearoa New Zealand. Read this microlearning to learn how health providers can help slow AMR, and find links to other resources.

Contributor
He Ako Hiringa
1 November 2023
  • HAH Bulletins
  • Antimicrobials

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • Next › Next page
  • Last » Last page
Home Home

Contact Us

Suite B, 2/20 Augustus Terrace, Parnell, Auckland 1052

PO Box 37590, Parnell, Auckland 1151

Support

09 488 4286

admin@akohiringa.co.nz

(9-5pm Mon-Fri)

Contact us

About us

Terms & Policies

  • Conditions for Use

Supported by

Pharmac

© Matui Limited. All rights reserved.

Developed by Matui Limited and brought to life by Communica.